Flora Growth Corp., an Ontario-based company, has announced a regulatory compliance issue following the passing of Harold Wolkin, an Independent Director. Mr. Wolkin served on the company's audit, compensation, and nominating and corporate governance committees. His passing has left Flora Growth's board with only two Independent Directors out of four members, falling short of the majority required by Nasdaq Listing Rule 5605(b)(1). Additionally, the company's audit committee is now comprised of only two members, not meeting the minimum of three Independent Directors as per Nasdaq Listing Rule 5605(c)(2)$(A)$. Flora Growth is currently exploring options to regain compliance with these Nasdaq rules within the designated cure period.